# REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

> **NCT06922175** · — · RECRUITING · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 200 (estimated)

## Conditions studied

- Epilepsy With Uncontrolled Focal-onset Seizures

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06922175
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922175, "REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06922175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*